UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck

Oral oncology, 2014-07, Vol.50 (7), p.627-632

2014

Volltextzugriff (PDF)

The role of human papillomavirus in nongenital cancers

CA: a cancer journal for clinicians, 2013-01, Vol.63 (1), p.57-81

2013

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.184-184, Article 184

2019

Volltextzugriff (PDF)

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Journal for immunotherapy of cancer, 2022-04, Vol.10 (4), p.e004424

2022

Volltextzugriff (PDF)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Frontiers in oncology, 2021-09, Vol.11, p.705614-705614

2021

Volltextzugriff (PDF)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002088

2021

Volltextzugriff (PDF)

Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity

Head & neck, 2019-08, Vol.41 (8), p.2514-2524

2019

Volltextzugriff (PDF)

Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients

Current treatment options in oncology, 2020-10, Vol.21 (12), p.92-92, Article 92

2020

Volltextzugriff (PDF)

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Nature reviews. Cancer, 2023-03, Vol.23 (3), p.173

2023

Volltextzugriff (PDF)

Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic Cancers

Current oncology (Toronto), 2023-09, Vol.30 (10), p.8826-8840

2023

Volltextzugriff (PDF)

Quality of life after radiation and transoral robotic surgery in advanced oropharyngeal cancer

Laryngoscope investigative otolaryngology, 2021-10, Vol.6 (5), p.983-990

2021

Volltextzugriff (PDF)

Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study

Cancer, 2021-06, Vol.127 (11), p.1779-1787

2021

Volltextzugriff (PDF)

The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment

Oral oncology, 2016-10, Vol.61, p.152-158

2016

Volltextzugriff (PDF)

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

Haematologica (Roma), 2013-04, Vol.98 (4), p.584-590

2013

Volltextzugriff (PDF)

PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma

Cancer Immunology, Immunotherapy, 2018-05, Vol.67 (5), p.805-814

2018

Volltextzugriff (PDF)

Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

European journal of cancer (1990), 2019-03, Vol.109, p.154-161

2019

Volltextzugriff (PDF)

Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database

Oral oncology, 2018-11, Vol.86, p.132-140

2018

Volltextzugriff (PDF)

Transition to a virtual multidisciplinary tumor board during the COVID‐19 pandemic: University of Pittsburgh experience

Head & neck, 2020-06, Vol.42 (6), p.1310-1316

2020

Volltextzugriff (PDF)

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2023-06, Vol.29 (11), p.2066-2074

2023

Volltextzugriff (PDF)

Genomic and transcriptomic analysis of cutaneous squamous cell carcinoma arising in immunocompetent and immunosuppressed patients

Oral oncology, 2024-01, Vol.148, p.106582, Article 106582

2024

Volltextzugriff (PDF)

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial

The Lancet (British edition), 2024-04, Vol.403 (10434), p.1351-1361

2024

Volltextzugriff (PDF)

Quality of Life in Patients With Recurrent and Second Primary Head and Neck Cancer

Otolaryngology-head and neck surgery, 2023-02, Vol.168 (2), p.196-202

2023

Volltextzugriff (PDF)

Cutaneous squamous cell carcinoma in the organ transplant recipient

Oral oncology, 2020-04, Vol.103, p.104562-104562, Article 104562

2020

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)
Bücher
(1)

Sprache

Englisch
(53)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(37)
Oncology
(35)
Female
(18)
Male
(18)
Immunotherapy
(17)
Squamous Cell Carcinoma
(16)
Tumors
(15)
Aged
(14)
Head & Neck Cancer
(14)
Middle Aged
(14)
Cancer
(13)
Adult
(12)
Head And Neck Neoplasms - Drug Therapy
(11)
Otorhinolaryngology
(11)
Patients
(11)
Retrospective Studies
(11)
Aged, 80 And Over
(10)
Cancer Therapies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck

The role of human papillomavirus in nongenital cancers

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck

Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity

Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic Cancers

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Quality of life after radiation and transoral robotic surgery in advanced oropharyngeal cancer

Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study

The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma

Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database

Transition to a virtual multidisciplinary tumor board during the COVID‐19 pandemic: University of Pittsburgh experience

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Genomic and transcriptomic analysis of cutaneous squamous cell carcinoma arising in immunocompetent and immunosuppressed patients

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial

Quality of Life in Patients With Recurrent and Second Primary Head and Neck Cancer

Cutaneous squamous cell carcinoma in the organ transplant recipient

Suchergebnisse filtern